Cafepharma Today

April 1 2025 - Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis
Widespread job cuts begin at health agencies
FTC concerned about privacy protections in 23andMe bankruptcy
Bausch + Lomb recalls Envista intraocular lenses over safety risks
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Investors Unimpressed By Abbott
Forbes
Thursday, October 16, 2008 - 9:03am
tags:
Wyeth postpones pursuing European approval for Pristiq as it conducts additional studies
Yahoo/AP
Thursday, October 16, 2008 - 9:02am
tags:
Pharma Not as Fazed by Wall Street Turmoil
PharmExec
Thursday, October 16, 2008 - 8:55am
tags:
For Lilly CEO John Lechleiter, risky deals are part of the job
Indianapolis Star, IN
Thursday, October 16, 2008 - 8:54am
tags:
Baxter Profit Rises 19%, Led By Blood Treatments
Bloomberg
Thursday, October 16, 2008 - 8:43am
tags:
Is FDA Watching YouTube?
PharmExec
Thursday, October 16, 2008 - 8:41am
tags:
Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
Yahoo
Wednesday, October 15, 2008 - 10:25am
tags:
Par reorganizes, drops 190 employees
Fierce Pharma
Wednesday, October 15, 2008 - 10:19am
tags:
Genentech-A-Go-Go: Our Lips Are Sealed
CNBC
Wednesday, October 15, 2008 - 10:17am
tags:
Johnson & Johnson: Is It Too Late?
Seeking Alpha
Wednesday, October 15, 2008 - 9:49am
tags:
The Strong Dollar May Hurt Pharma Earnings
Pharmalot
Wednesday, October 15, 2008 - 8:49am
tags:
Abbott Labs profit soars 51 percent, raises forecast
Yahoo/Reuters
Wednesday, October 15, 2008 - 8:41am
tags:
Abbott: Progress on Dissolving Stent
Businessweek
Wednesday, October 15, 2008 - 8:40am
tags:
Alcon signs licensing deal with GlaxoSmithKline for potential eye-care product
Yahoo/AP
Wednesday, October 15, 2008 - 8:38am
tags:
Glaxo to pay $210 mln for Bristol-Myers Egypt unit
Marketwatch
Wednesday, October 15, 2008 - 8:37am
tags:
Johnson & Johnson Takes Good Care of Business
Seeking Alpha
Wednesday, October 15, 2008 - 8:36am
tags:
Genentech Profit Rises on Strong Sales
The Street.com
Tuesday, October 14, 2008 - 6:42pm
tags:
Ely Lilly Scoops Up ImClone
Forbes
Tuesday, October 14, 2008 - 6:38pm
tags:
Johnson & Johnson, Heal Thyself
Motley Fool
Tuesday, October 14, 2008 - 6:37pm
tags:
Despite Crisis, U.S. Drug Companies’ Cash Is Safe*
WSJ Online
Tuesday, October 14, 2008 - 6:36pm
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

A New Pan-Coronovirus Protease Inhibitor Possibility
In the Pipeline
Pain Continues to Be a Pain
In the Pipeline
Alkanes on Mars
In the Pipeline
Starving Cancer Cells Where They Live
In the Pipeline
Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Evolving the Ability to Evolve
In the Pipeline
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.